Privia Health (PRVA) revenue breakdown
By product, FFS-patient care is the largest at 64% of fiscal 2025 revenue; Shared savings grew fastest, 34% a year over 6 years.
Revenue by product
Fiscal years, as Privia Health reports them in its 10-K filings; fiscal 2025 total $2.1B.
| Products | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|
| FFS-patient care | $676M | $647M | $772M | $869M | $977M | $1.1B | $1.4B | 64% |
| Capitated revenue | — | — | — | $218M | $339M | $213M | $308M | 15% |
| Shared savings | $40M | $66M | $83M | $133M | $170M | $179M | $235M | 11% |
| FFS-administrative services | $49M | $58M | $69M | $95M | $113M | $125M | $137M | 6% |
| Care management fees (PMPM) | $19M | $27M | $37M | $36M | $51M | $64M | $73M | 3% |
| Other revenue | $3M | $18M | $5M | $6M | $9M | $9M | $9M | 0% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for PRVA.
Open PRVA in InvestinglyQuestions
Where does Privia Health make its money?
In fiscal 2025, by product: FFS-patient care $1.4B, Capitated revenue $308M, Shared savings $235M, FFS-administrative services $137M, Care management fees (PMPM) $73M.
From Privia Health's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.